Skip to content
Inciteful Med
Resources About us Ask a Question

Understanding Lemierre Syndrome: From Sore Throat to Hospitalization

Published: | Updated:

At a Glance

Lemierre syndrome is a rare, severe complication of a common sore throat, most often affecting young adults. It occurs when bacteria invade the internal jugular vein in the neck, causing an infected blood clot. It is highly treatable with a 4 to 6-week course of intensive antibiotics.

Key Takeaways

  • • Lemierre syndrome is a rare complication that usually begins as a common throat infection in adolescents and young adults.
  • • It occurs when bacteria, most commonly Fusobacterium necrophorum, invade the internal jugular vein and cause an infected blood clot.
  • • The severe progression of the infection into Lemierre syndrome is not contagious to family or friends.
  • • Fragments of the infected clot can break off and travel to the lungs, a condition known as septic emboli.
  • • The condition is highly treatable with modern medicine, requiring 4 to 6 weeks of intensive antibiotic therapy.

It is deeply disorienting to go from being a healthy teenager or young adult with a “simple” sore throat to suddenly being in a hospital bed facing a diagnosis with complex names like Lemierre Syndrome [1][2]. This experience can feel like medical whiplash, but understanding the mechanics of what is happening in the body can help replace fear with clarity.

Why This Happens to Healthy Young People

Lemierre syndrome is a rare condition that most often affects adolescents and young adults between the ages of 15 and 24 [3][1]. It typically begins with a common throat infection, such as tonsillitis [4].

In a very small number of cases—estimated at about 9.4 cases per million people in your age group annually—a specific bacteria behaves more aggressively than usual [3][4]. The most common culprit is Fusobacterium necrophorum. This bacteria has unique tools, such as a leukotoxin (a substance that damages white blood cells), which allow it to move past the surface of the throat and invade deeper tissues [5][6].

Is it contagious? A common and immediate fear is whether you exposed your friends, siblings, or roommates. While the initial sore throat might have been contagious, the severe progression into Lemierre syndrome is not considered a contagious event. It is a rare, individual complication of a bacteria that naturally lives in the mouth [5][4].

Demystifying the Diagnosis

When doctors use certain terms, they are describing a specific sequence of events that the medical team is now actively managing:

  • Septic Thrombophlebitis: This is the medical term for an infected blood clot inside a vein [7]. In Lemierre syndrome, the bacteria travel from the throat into the nearby internal jugular vein (the large vein in the neck) [4]. The infection causes the wall of the vein to become inflamed, which triggers the body to form a clot (thrombus) [8][9].
  • Septic Emboli: These are tiny pieces of that infected clot that break off and travel through the bloodstream [10][7]. Think of them as small “seeds” of infection. Because of how blood flows, these seeds usually travel to the lungs first, where they may cause small areas of infection or inflammation [11][7].

Stabilizing Facts and Recovery

While the diagnosis is serious, modern medicine is highly effective at treating Lemierre syndrome.

  • Antibiotics are Powerful: The core of treatment is intensive, long-term antibiotic therapy [12]. These medications are specifically chosen to target the bacteria and are very successful at clearing the infection [13].
  • Declining Mortality: While this was a much more dangerous condition in the era before antibiotics, the outlook has improved significantly with modern imaging (like CT scans) and prompt treatment [14][15].
  • Comprehensive Care: Your team may use various tools to monitor the clot and the lungs, such as POCUS (point-of-care ultrasound) or follow-up CT scans, to ensure the infection is receding [16][17].
  • Managing the Clot: While the use of anticoagulation (blood thinners) is decided on a case-by-case basis, many patients recover fully with antibiotics alone as the body naturally dissolves the clot once the infection is gone [18][19].

What to Expect Next

Recovery from Lemierre syndrome is a marathon, not a sprint. Treatment usually involves 4 to 6 weeks of antibiotics—often starting with an IV in the hospital and potentially transitioning to home care—to ensure the bacteria are completely eradicated from the vein and the lungs [12][20]. Throughout this process, the medical team’s primary goal is to support the body while the medications do the heavy lifting of clearing the infection.

Frequently Asked Questions

Is Lemierre syndrome contagious?
While the initial sore throat might have been contagious, the severe progression into Lemierre syndrome is not. It is a rare, individual complication caused by a specific bacteria that already naturally lives in the mouth.
What does septic thrombophlebitis mean?
Septic thrombophlebitis is the medical term for an infected blood clot inside a vein. In Lemierre syndrome, bacteria travel from the throat into the internal jugular vein in the neck, causing inflammation that triggers a clot to form.
What are septic emboli?
Septic emboli are tiny pieces of an infected clot that break off and travel through the bloodstream. In Lemierre syndrome, these infected fragments usually travel to the lungs, where they can cause small areas of infection or inflammation.
How is Lemierre syndrome treated?
The core treatment is intensive, long-term antibiotic therapy, typically lasting 4 to 6 weeks. Treatment usually starts with intravenous (IV) antibiotics in the hospital, and doctors may also prescribe blood thinners on a case-by-case basis to manage the blood clot.
How long does it take to recover from Lemierre syndrome?
Recovery usually involves 4 to 6 weeks of antibiotics to ensure the bacteria are completely eradicated from your vein and lungs. You will likely start with IV medications in the hospital before transitioning to oral antibiotics at home.

Questions for Your Doctor

  • • What bacteria were identified in my (or my child's) blood cultures, and how does that guide the choice of antibiotics?
  • • Given the presence of internal jugular vein thrombosis, what is the team's rationale for either using or not using anticoagulation (blood thinners) in this case?
  • • What do the chest imaging results show regarding the septic emboli, and how will we monitor their resolution?
  • • How many weeks of antibiotic treatment should we expect, and what are the milestones for transitioning from IV to oral medication?
  • • What specific signs of improvement or new complications (like joint pain or breathing changes) should we be watching for over the next few days?

Questions for You

  • • How has the pain in the neck or throat changed since starting treatment?
  • • When did the symptoms first shift from a typical sore throat to more severe symptoms like high fever, neck swelling, or difficulty breathing?
  • • Are there any new areas of pain or discomfort in the body, such as in the chest, joints, or abdomen, that haven't been discussed with the medical team?

Want personalized information?

Type your question below to get evidence-based answers tailored to your situation.

Mapping the Infection: How Lemierre Syndrome Is Diagnosed Lemierre syndrome

References

  1. 1

    Patients with Lemierre syndrome have a high risk of new thromboembolic complications, clinical sequelae and death: an analysis of 712 cases.

    Valerio L, Zane F, Sacco C, et al.

    Journal of internal medicine 2021; (289(3)):325-339 doi:10.1111/joim.13114.

    PMID: 32445216
  2. 2

    Forget-me-not: Lemierre's syndrome, a case report.

    Silverberg B, Sharon MJ, Makati D, et al.

    Journal of American college health : J of ACH 2023; (71(2)):343-347 doi:10.1080/07448481.2021.1899190.

    PMID: 33760711
  3. 3

    Fusobacterium necrophorum findings in Denmark from 2010 to 2014 using data from the Danish microbiology database.

    Bank S, Jensen A, Nielsen HM, et al.

    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2016; (124(12)):1087-1092 doi:10.1111/apm.12606.

    PMID: 27704629
  4. 4

    An unusual case of Lemierre syndrome - One pathogen or two?

    O'Shaughnessy M, Irizarry D, Finkel D

    IDCases 2021; (25()):e01203 doi:10.1016/j.idcr.2021.e01203.

    PMID: 34221895
  5. 5

    Fusobacterium necrophorum Promotes Apoptosis and Inflammatory Cytokine Production Through the Activation of NF-κB and Death Receptor Signaling Pathways.

    Wang FF, Zhao PY, He XJ, et al.

    Frontiers in cellular and infection microbiology 2022; (12()):827750 doi:10.3389/fcimb.2022.827750.

    PMID: 35774408
  6. 6

    Three variants of the leukotoxin gene in human isolates of Fusobacterium necrophorum subspecies funduliforme.

    Holm K, Collin M, Hagelskjær-Kristensen L, et al.

    Anaerobe 2017; (45()):129-132 doi:10.1016/j.anaerobe.2017.03.016.

    PMID: 28330774
  7. 7

    Ophthalmic complications of Lemierre syndrome.

    Kreuzpointner R, Valerio L, Corsi G, et al.

    Acta ophthalmologica 2022; (100(1)):e314-e320 doi:10.1111/aos.14871.

    PMID: 33829646
  8. 8

    [A sepsis that you don't expect… Lemierre's syndrome. Description of a clinical case.]

    Dal Bo S, Calandriello L, Biserna L, et al.

    Recenti progressi in medicina 2019; (110(11)):543-547 doi:10.1701/3265.32329.

    PMID: 31808441
  9. 9

    Invasive Fusobacterium necrophorum infections and Lemièrre's syndrome: the role of thrombophilia and EBV.

    Holm K, Svensson PJ, Rasmussen M

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 2015; (34(11)):2199-207 doi:10.1007/s10096-015-2469-8.

    PMID: 26272176
  10. 10

    Lemierre's syndrome: a disguised threat.

    Alves S, Stella L, Carvalho I, Moreira D

    BMJ case reports 2019; (12(4)) doi:10.1136/bcr-2018-228397.

    PMID: 31015242
  11. 11

    [Cervicofacial cellulitis complicated by internal jugular vein thrombosis].

    Bonné E, Pourcelet A, Del Marmol V, Couturier B

    Annales de dermatologie et de venereologie 2020; (147(10)):643-647 doi:10.1016/j.annder.2020.04.013.

    PMID: 32505376
  12. 12

    Atypical involvement of the thyro-linguo-facial vein in Lemierre syndrome.

    Constans S, Bosshard T, Petignat PA, Le Peillet D

    BMJ case reports 2022; (15(11)) doi:10.1136/bcr-2022-251722.

    PMID: 36379635
  13. 13

    Lemierre syndrome caused by Klebsiella pneumoniae complicated by epidural abscess - Case report.

    Sabaka P, Kachlíková M, Bendžala M, Káčerová H

    IDCases 2020; (19()):e00664 doi:10.1016/j.idcr.2019.e00664.

    PMID: 32226757
  14. 14

    Lemierre syndrome: Current evidence and rationale of the Bacteria-Associated Thrombosis, Thrombophlebitis and LEmierre syndrome (BATTLE) registry.

    Valerio L, Corsi G, Sebastian T, Barco S

    Thrombosis research 2020; (196()):494-499 doi:10.1016/j.thromres.2020.10.002.

    PMID: 33091703
  15. 15

    A Rare Case Report of Lemierre Syndrome from the Anterior Jugular Vein.

    Rejali N, Heyer M, Finefrock D

    Clinical practice and cases in emergency medicine 2020; (4(3)):454-457 doi:10.5811/cpcem.2020.7.47442.

    PMID: 32926711
  16. 16

    Point-of-care ultrasound for Lemierre's syndrome during the COVID-19 pandemic: A case report.

    Kawai Y, Nishiyama K

    Journal of general and family medicine 2024; (25(5)):274-276 doi:10.1002/jgf2.708.

    PMID: 39574551
  17. 17

    Diagnosis and Management of Lemierre's Syndrome Presented with Multifocal Pneumonia and Cerebral Venous Sinus Thrombosis.

    Sattar Y, Susheela AT, Karki B, et al.

    Case reports in infectious diseases 2020; (2020()):6396274 doi:10.1155/2020/6396274.

    PMID: 32231820
  18. 18

    Lemierre Syndrome: A Meta-analysis.

    Gore MR

    International archives of otorhinolaryngology 2020; (24(3)):e379-e385 doi:10.1055/s-0039-3402433.

    PMID: 32754251
  19. 19

    Jugular Vein Thrombosis and Anticoagulation Therapy in Lemierre's Syndrome-A Post Hoc Observational and Population-Based Study of 82 Patients.

    Nygren D, Elf J, Torisson G, Holm K

    Open forum infectious diseases 2021; (8(1)):ofaa585 doi:10.1093/ofid/ofaa585.

    PMID: 33447643
  20. 20

    [Suppurative Thrombophlebitis of the Posterior Neck Caused by Streptococcus constellatus: A Case Report and Literature Review].

    Takada K, Nakamura M, Samura M, et al.

    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2022; (142(2)):189-193 doi:10.1248/yakushi.21-00179.

    PMID: 35110455

This page provides educational information about Lemierre syndrome and its progression. It is not a substitute for professional medical advice, diagnosis, or treatment from your healthcare team.

Stay up to date

Get notified when new research about Lemierre syndrome is published.

No spam. Unsubscribe anytime.